Peter Kaiser Ocular Therapeutix, Inc (OCUL) insider trading activity

Peter Kaiser is Chief Development Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 271,918 shares of OCUL, which is worth approximately $3.09 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 79,112 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 272K

39.85% 3M change

27.61% 12M change

Total Value Held $3.09 Million

Peter Kaiser Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	79,112 Added 22.54%	271,918 Common Stock
Nov 24 2025	SELL Open market or private sale	$36,144 $12.02 p/Share	3,007 Reduced 1.55%	191,433 Common Stock
Oct 02 2025	SELL Open market or private sale	$106,472 $11.03 p/Share	9,653 Reduced 4.73%	194,440 Common Stock
Aug 25 2025	SELL Open market or private sale	$36,252 $12.04 p/Share	3,011 Reduced 1.45%	204,093 Common Stock
May 23 2025	SELL Open market or private sale	$21,323 $7.17 p/Share	2,974 Reduced 1.42%	207,104 Common Stock
Feb 24 2025	SELL Open market or private sale	$20,671 $6.87 p/Share	3,009 Reduced 1.41%	210,078 Common Stock
Nov 25 2024	SELL Open market or private sale	$26,101 $9.01 p/Share	2,897 Reduced 1.34%	213,087 Common Stock

Oct 02 2024	BUY Grant, award, or other acquisition	-	100,000 Added 31.65%	215,984 Common Stock

Peter Kaiser

Chief Development Officer

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Value

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

Operation

Value

Type

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL

Account